Investor’s Toolkit: Key Ratios for Assessing Amprius Technologies Inc (AMPX)’s Performance

Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.

Amprius Technologies Inc (NYSE: AMPX) closed the day trading at $1.42 down -27.92% from the previous closing price of $1.97. In other words, the price has decreased by -$27.92 from its previous closing price. On the day, 5.02 million shares were traded. AMPX stock price reached its highest trading level at $1.42 during the session, while it also had its lowest trading level at $1.27.

Ratios:

For a better understanding of AMPX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.64 and its Current Ratio is at 3.70. In the meantime, Its Debt-to-Equity ratio is 0.59 whereas as Long-Term Debt/Eq ratio is at 0.58.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, ROTH MKM on January 11, 2024, initiated with a Buy rating and assigned the stock a target price of $10.

On December 05, 2023, Alliance Global Partners started tracking the stock assigning a Buy rating and target price of $10.Alliance Global Partners initiated its Buy rating on December 05, 2023, with a $10 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 02 ’24 when Bornstein Jonathan sold 125,983 shares for $2.38 per share. The transaction valued at 299,613 led to the insider holds 558,930 shares of the business.

Bornstein Jonathan sold 40,200 shares of AMPX for $111,579 on Mar 06 ’24. The President of Amprius Lab now owns 0 shares after completing the transaction at $2.78 per share. On Mar 05 ’24, another insider, Bornstein Jonathan, who serves as the President of Amprius Lab of the company, sold 109,800 shares for $2.92 each. As a result, the insider received 320,462 and left with 0 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMPX now has a Market Capitalization of 134151232 and an Enterprise Value of 131192168. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.81 while its Price-to-Book (P/B) ratio in mrq is 2.11. Its current Enterprise Value per Revenue stands at 12.25 whereas that against EBITDA is -3.558.

Stock Price History:

The Beta on a monthly basis for AMPX is 2.99, which has changed by -0.8346915 over the last 52 weeks, in comparison to a change of 0.2704494 over the same period for the S&P500. Over the past 52 weeks, AMPX has reached a high of $10.63, while it has fallen to a 52-week low of $1.56. The 50-Day Moving Average of the stock is -38.33%, while the 200-Day Moving Average is calculated to be -62.83%.

Shares Statistics:

Over the past 3-months, AMPX traded about 620.60K shares per day on average, while over the past 10 days, AMPX traded about 1055490 shares per day. A total of 88.87M shares are outstanding, with a floating share count of 15.60M. Insiders hold about 83.47% of the company’s shares, while institutions hold 4.63% stake in the company. Shares short for AMPX as of 1714435200 were 1832366 with a Short Ratio of 2.95, compared to 1711584000 on 1592863. Therefore, it implies a Short% of Shares Outstanding of 1832366 and a Short% of Float of 8.930001.

Most Popular

[the_ad id="945"]